convert
enzym
receptor
hypertens
preexist
cardiovascular
diseas
risk
factor
morbid
remain
uncertain
whether
use
angiotensin
convert
enzym
inhibitor
acei
angiotensin
receptor
blocker
arb
impact
infect
diseas
aim
shed
light
question
assess
express
normal
diseas
human
myocardi
sampl
profil
bulk
singl
nucleu
rnaseq
predomin
portal
entri
via
express
upper
respiratori
epithelium
lung
yet
also
abundantli
express
intestin
kidney
heart
test
observ
twenti
percent
hospit
patient
wuhan
china
evid
cardiac
injuri
resuggest
possibl
patholog
role
myocardi
express
singlecent
report
patient
hospit
evid
cardiac
injuri
moreov
presenc
cardiac
injuri
associ
increas
mechan
ventil
mortal
rate
context
potenti
primari
viral
myocard
gain
support
prior
find
viral
rna
also
infect
cell
via
autopsi
heart
earlier
sarscov
epidem
lend
credenc
possibl
involv
pathogenesi
led
consider
whether
inhibitor
angiotensin
convert
enzym
acei
angiotensin
receptor
blocker
arb
might
modul
diseas
progress
increas
express
inde
trial
propos
test
impact
initi
withdraw
agent
advanc
current
pandem
uncertainti
provok
public
statement
three
lead
cardiovascular
societi
advis
continu
agent
absenc
compel
new
data
address
question
assess
express
normal
diseas
human
myocardi
sampl
penn
human
heart
tissu
biobank
bulk
singl
nucleu
rnaseq
group
previous
util
approach
studi
transcript
divers
cell
subtyp
associ
gene
program
normal
human
heart
express
assess
left
ventricl
individu
dilat
cardiomyopathi
dcm
individu
hypertroph
cardiomyopathi
hcm
nonfail
control
defin
individu
without
overt
indic
cardiac
dysfunct
baselin
characterist
studi
popul
provid
supplementari
tabl
exploratori
analysi
effect
acei
treatment
express
evalu
subset
patient
hcm
six
individu
receiv
acei
eight
prescrib
acei
express
heart
strongest
pericyt
line
microvasculatur
also
appreci
vascular
smooth
muscl
cell
fibroblast
cardiomyocyt
fig
also
evalu
express
proteas
encod
ctsl
facilit
membran
fusion
viral
uptak
infect
minim
express
across
cell
type
ctsl
display
low
level
express
cell
type
strongest
express
fibroblast
cell
two
popul
found
nonfail
control
macrophag
adipocyt
cardiomyocyt
supplementari
fig
result
concord
recent
releas
singl
nuclei
data
chen
et
al
analys
previous
gener
bulk
rnaseq
data
individu
show
signific
alter
express
context
dilat
hypertroph
cardiomyopathi
compar
nonfail
control
fig
howev
singl
nucleu
rnaseq
highlight
stark
downregul
express
fibroblast
pericyt
vascular
smooth
muscl
concomit
upregul
express
cardiomyocyt
dcm
hcm
fig
complet
cell
subtyp
differenti
express
analysi
dcm
hcm
compar
nonfail
control
provid
supplementari
tabl
respect
sensit
analysi
compar
express
left
ventricl
sampl
individu
hypertroph
cardiomyopathi
compar
nonfail
control
exclus
individu
ace
inhibitor
arb
provid
supplementari
tabl
sinc
patient
dcm
acei
nonfail
control
acei
abil
examin
effect
acei
use
express
limit
patient
hcm
among
patient
trend
toward
increas
express
acei
treatment
cell
type
fig
supplementari
tabl
result
statist
signific
futur
studi
larger
patient
cohort
examin
cell
type
specif
express
addit
diseas
state
nonfail
donor
receiv
acei
arb
urgent
need
import
note
transcript
assess
reflect
effect
rna
halflif
translat
effici
protein
turnov
import
surfac
local
protein
also
evalu
futur
studi
conclus
data
suggest
prior
cardiovascular
diseas
predomin
driver
cardiomyocytespecif
increas
transcript
find
may
provid
patholog
link
sarscovassoci
viral
myocard
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
